Literature DB >> 24930707

Antigen-specific H1N1 influenza antibody responses in acute respiratory tract infections and their relation to influenza infection and disease course.

John Patrick Haran1, David C Hoaglin2, Huaiqing Chen3, Edward W Boyer4, Shan Lu3.   

Abstract

BACKGROUND: Early antibody responses to influenza infection are important in both clearance of virus and fighting the disease. Acute influenza antibody titers directed toward H1-antigens and their relation to infection type and patient outcomes have not been well investigated.
OBJECTIVE: Using hemagglutination inhibition (HI) assays, we aimed to characterize the H1-specific antibody titers in patients with influenza infection or another respiratory infection before and after the H1N1-pandemic influenza outbreak. Among patients with acute influenza infection we related duration of illness, severity of symptoms, and need for hospitalization to antibody titers.
METHODS: There were 134 adult patients (average age 34.7) who presented to an urban academic emergency department (ED) from October through March during the 2008-2011 influenza seasons with symptoms of fever and a cough. Nasal aspirates were tested by viral culture, and peripheral blood serum was run in seven H1-subtype HI assays.
RESULTS: Acutely infected influenza patients had markedly lower antibody titers for six of the seven pseudotype viruses. For the average over the seven titers (log units, base 2) their mean was 7.24 (95% CI 6.88, 7.61) compared with 8.60 (95% CI 8.27, 8.92) among patients who had a non-influenza respiratory illness, p<0.0001. Among patients with seasonal influenza infection, titers of some antibodies correlated with severity of symptoms and with total duration of illness (p<0.02).
CONCLUSION: In patients with acute respiratory infections, lower concentrations of H1-influenza-specific antibodies were associated with influenza infection. Among influenza-infected patients, higher antibody titers were present in patients with a longer duration of illness and with higher severity-of-symptom scores.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibodies; Bacterial pneumonia; H1N1 influenza; Seasonal influenza

Mesh:

Substances:

Year:  2014        PMID: 24930707      PMCID: PMC4465089          DOI: 10.1016/j.jcv.2014.04.017

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  27 in total

1.  Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.

Authors:  Shixia Wang; Jessica Taaffe; Christopher Parker; Alicia Solórzano; Hong Cao; Adolfo García-Sastre; Shan Lu
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

2.  Pulmonary complications of interpandemic influenza A in hospitalized adults.

Authors:  Yoshihiko Murata; Edward E Walsh; Ann R Falsey
Journal:  J Infect Dis       Date:  2007-02-15       Impact factor: 5.226

3.  Severe respiratory disease concurrent with the circulation of H1N1 influenza.

Authors:  Gerardo Chowell; Stefano M Bertozzi; M Arantxa Colchero; Hugo Lopez-Gatell; Celia Alpuche-Aranda; Mauricio Hernandez; Mark A Miller
Journal:  N Engl J Med       Date:  2009-06-29       Impact factor: 91.245

4.  Original antigenic sin in ferrets: the response to sequential infections with influenza viruses.

Authors:  R G Webster
Journal:  J Immunol       Date:  1966-08       Impact factor: 5.422

5.  Clinical signs and symptoms predicting influenza infection.

Authors:  A S Monto; S Gravenstein; M Elliott; M Colopy; J Schweinle
Journal:  Arch Intern Med       Date:  2000-11-27

6.  Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza.

Authors:  J T Whicher; R E Chambers; J Higginson; L Nashef; P G Higgins
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

7.  Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha.

Authors:  Lisa M Sedger; Sam Hou; Sarah R Osvath; Moira B Glaccum; Jacques J Peschon; Nico van Rooijen; Lisa Hyland
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

8.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.

Authors:  Jens Wrammert; Kenneth Smith; Joe Miller; William A Langley; Kenneth Kokko; Christian Larsen; Nai-Ying Zheng; Israel Mays; Lori Garman; Christina Helms; Judith James; Gillian M Air; J Donald Capra; Rafi Ahmed; Patrick C Wilson
Journal:  Nature       Date:  2008-04-30       Impact factor: 49.962

9.  Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity.

Authors:  Zhi-Yong Yang; Chih-Jen Wei; Wing-Pui Kong; Lan Wu; Ling Xu; David F Smith; Gary J Nabel
Journal:  Science       Date:  2007-08-10       Impact factor: 47.728

Review 10.  Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans.

Authors:  J S Malik Peiris; Leo L M Poon; Yi Guan
Journal:  J Clin Virol       Date:  2009-06-11       Impact factor: 3.168

View more
  3 in total

1.  Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.

Authors:  Gro Tunheim; Ida Laake; Anna Hayman Robertson; Kristian Waalen; Olav Hungnes; Lisbeth M Naess; Rebecca J Cox; Siri Mjaaland; Lill Trogstad
Journal:  Influenza Other Respir Viruses       Date:  2019-01-01       Impact factor: 4.380

2.  Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection.

Authors:  Xiuhua Lu; Zhu Guo; Zhu-Nan Li; Crystal Holiday; Feng Liu; Stacie Jefferson; F Liaini Gross; Wen-Ping Tzeng; Anand Kumar; Ian A York; Timothy M Uyeki; Terrence Tumpey; James Stevens; Min Z Levine
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

3.  Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.

Authors:  Kristin G-I Mohn; Rebecca Jane Cox; Gro Tunheim; Jan Erik Berdal; Anna Germundsson Hauge; Åsne Jul-Larsen; Bjoern Peters; Fredrik Oftung; Christine Monceyron Jonassen; Siri Mjaaland
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.